203
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Lactoferrin versus Long-Acting Penicillin in Reducing Elevated Anti-Streptolysin O Titer in Cases of Tonsillopharyngitis

, ORCID Icon, ORCID Icon, , , , , & ORCID Icon show all
Pages 5257-5263 | Published online: 06 Sep 2022

References

  • Lau AS, Upile NS, Wilkie MD, Leong SC, Swift AC. The rising rate of admissions for tonsillitis and neck space abscesses in England, 1991–2011. Annals Royal Coll Surg Engl. 2014;96(4):307–310. doi:10.1308/003588414X13946184900363
  • Klug TE. Peritonsillar abscess: clinical aspects of microbiology, risk factors, and the association with parapharyngeal abscess. Clin Infect Dis. 2009;49:1467–1472.
  • Borgström A, Nerfeldt P, Friberg D, Sunnergren O, Stalfors J. Trends and changes in paediatric tonsil surgery in Sweden 1987–2013: a population-based cohort study. BMJOPEN. 2017;7(1):e013346.
  • Brook I, Gober AE. Increased recovery of Moraxella catarrhalis and Haemophilus influenzae in association with group a b-haemolytic streptococci in healthy children and those with pharyngotonsillitis. J Med Microbiol. 2006;55:998–1092. doi:10.1099/jmm.0.46325-0
  • Hammouda M, Abdel-Khalek Z, Awad S, Abdel-Aziz M, Fathy M. Chronic tonsillitis bacteriology in Egyptian children including antimicrobial susceptibility. Aust J Basic Appl Sci. 2009;3:1948–1953.
  • Burton MJ, Glasziou PP. Tonsillectomy or adenotonsillectomy versus nonsurgical treatment for chronic/recurrent acute tonsillitis. Cochrane Database Syst Rev. 2009;CD001802. doi:10.1002/14651858.CD001802.pub2
  • Awad Z, Al-Yaghchi C, Anwar M, Georgalas C, Narula A. Does tonsillectomy help children with recurrent tonsillitis? Otolaryngol Head Neck Surg. 2010;143(l):113–116. doi:10.1016/j.otohns.2010.06.207
  • Kaplan EL, Rothermel CD, Johnson DR. Antistreptolysin O and anti-deoxyribonuclease B titers: normal values for children ages 2 to 12 in the United States. Pediatrics. 1998;101:86–88. doi:10.1542/peds.101.1.86
  • Millington AJ, Phillips JS. Current trends in tonsillitis and tonsillectomy. Annals Royal Coll Surg Engl. 2014;96(8):586–589. doi:10.1308/003588414X13946184901966
  • Dajani A, Taubert K, Ferrieri P, et al. Treatment of acute streptococcal pharyngitis and prevention of rheumatic fever: a statement for health professionals. Pediatrics. 1995;96(4):758–764. doi:10.1542/peds.96.4.758
  • Anderson BF, Baker HM, Norris GE, Rumball SV, Baker EN. Apolactoferrin structure demonstrates ligand-induced conformational change in transferrins. Nature. 1990;344:784–787. doi:10.1038/344784a0
  • Vogel HJ. Lactoferrin, a bird’s eye view. Biochem Cell Biol. 2012;90:233–244. doi:10.1139/o2012-016
  • Karav S, German JB, Rouquié C, Le Parc A, Barile D. Studying lactoferrin N-glycosylation. Int J Mol Sci. 2017;18:E870. doi:10.3390/ijms18040870
  • Karav S. Selective deglycosylation of lactoferrin to understand glycans’contribution to antimicrobial activity of lactoferrin. Cell Mol Biol. 2018;64:52–57. doi:10.14715/cmb/2018.64.9.8
  • Moore SA, Anderson BF, Groom CR, Haridas M, Baker EN. Threedimensional structure of diferric bovine lactoferrin at 2.8A resolution. J Mol Biol. 1997;274:222–236. doi:10.1006/jmbi.1997.1386
  • Sorensen M, Sorensen S. Report of the Works of the Carlsberg Laboratory. Copenhagen 48- Lactoferrin: industrial production and applications. Rev Mex Pharmaceutical Sciences; 1939.
  • Van Der Strate BWA, Belijaars L, Molema G, Harmsen MC, Meijer DKF. Antiviral activities of lactoferrin. Antiviral Res. 2001;52:225–239. doi:10.1016/S0166-3542(01)00195-4
  • Valenti A, Antonini G. Lactoferrin: an important host defense against microbial and viral attack. Cell Mol Life Sci. 2005;62:2576–2587. doi:10.1007/s00018-005-5372-0
  • Damiens E, El Yazidi I, Mazurier J, et al. Role of heparan sulphate proteoglycans in the regulation of human lactoferrin binding and activity in the MDA-MB-231 breast cancer cell line. Eur J Cell Biol. 1998;77:344–351. doi:10.1016/S0171-9335(98)80093-9
  • Shau H, Kim A, Golub SH. Modulation of natural killer and lymphokine-activated killer cell cytotoxicity by lactoferrin. J Leukoc Biol. 1992;51:343–349. doi:10.1002/jlb.51.4.343
  • Arnold RR, Russell JE, Champion WJ, Gauthier JJ. Bactericidal activity of human lactoferrin: influence of physical conditions and metabolic state of the target microorganism. Infect Immun. 1981;32:655–660. doi:10.1128/iai.32.2.655-660.1981
  • Velliyagounder K, Kaplan JB, Furgang D, et al. One of two human lactoferrin variants exhibits increased antibacterial and transcriptional activation activities and is associated with localized juvenile periodontitis. Infect Immun. 2003;71:6141–6147. doi:10.1128/IAI.71.11.6141-6147.2003
  • Sidell D, Shapiro NL. Acute tonsillitis. Infect Disord Drug Targets. 2012;12(4):271–276. doi:10.2174/187152612801319230
  • Demir UL, Cetinkaya B, Karaca S, Sigirli D. The impacts of adenotonsillar Hypertrophy on periodontal health in children: aprospective controlled pilot study. Am J Otolaryngol. 2013;34(5):501–504. doi:10.1016/j.amjoto.2013.04.013
  • Lang J, Yang N, Deng J, et al. Inhibition of SARS pseudovirus cell entry by lactoferrin binding to heparan sulfate proteoglycans. PLoS One. 2011;6:e23710. doi:10.1371/journal.pone.0023710
  • Redwan EM, Uversky VN, El-Fakharany EM, Al-Mehdar H. Potential lactoferrin activity against pathogenic viruses. C R Biol. 2014;337:581–595. doi:10.1016/j.crvi.2014.08.003
  • Chen JM, Fan YC, Lin JW, Chen YY, Hsu WL, Chiou SS. Bovine lactoferrin inhibits dengue virus infectivity by interacting with heparan sulfate, low density lipoprotein receptor, and DC-SIGN. Int J Mol Sci. 2017;18:E1957. doi:10.3390/ijms18091957
  • Carvalho CAM, Casseb SMM, Goncalves RB, Silva EVP, Gomes AMO, Vasconcelos PFC. Bovine lactoferrin activity against Chikungunya and Zika viruses. J Gen Virol. 2017;98:1749–1754. doi:10.1099/jgv.0.000849
  • Rosa L, Cutone A, Lepanto MS, Paesano R, Valenti P. Lactoferrin: a natural glycoprotein involved in iron and inflammatory homeostasis. Int J Mol Sci. 2017;18:1985. doi:10.3390/ijms18091985
  • Petrik M, Zhai C, Haas H, Decristoforo C. Siderophores for molecular imaging applications. Clin Transl Imaging. 2017;5:15–27. doi:10.1007/s40336-016-0211-x
  • Beddek AJ, Schryvers AB. The lactoferrin receptor complex in Gram negative bacteria. Biometals. 2010;23:377–386. doi:10.1007/s10534-010-9299-z
  • Pogoutse AK, Moraes TF. Iron acquisition through the bacterial transferrin receptor. Crit Rev Biochem Mol Biol. 2017;52:314–326. doi:10.1080/10409238.2017.1293606
  • Wandersman C, Stojiljkovic I. Bacterial heme sources: the role of heme, hemoprotein receptors and hemophores. Curr Opin Microbiol. 2000;3:215–220. doi:10.1016/S1369-5274(00)00078-3
  • Huang W, Wilks A. Extracellular heme uptake and the challenge of bacterial cell membranes. Annu Rev Biochem. 2017;86:799–823. doi:10.1146/annurev-biochem-060815-014214
  • Lepanto MS, Rosa L, Paesano R, Valenti P, Cutone A. Lactoferrin in aseptic and septic inflammation. Molecules. 2019;24:1323. doi:10.3390/molecules24071323
  • Fernandes KE, Carter DA. The antifungal activity of lactoferrin and its derived peptides: mechanisms of action and synergy with drugs against fungal pathogens. FrontMicrobiol. 2017;8:2. doi:10.3389/fmicb.2017.00002
  • Liao H, Liu S, Wang H, Su H, Liu Z. Enhanced antifungal activity of bovine lactoferrin-producing probiotic Lactobacillus casei in the murine model of vulvovaginal candidiasis. BMC Microbiol. 2019;19:7. doi:10.1186/s12866-018-1370-x
  • Andrés MT, Acosta-Zaldívar M, Fierro JF. Antifungal mechanism of action of lactoferrin: identification of H+-ATPase (P3A-type) as a new apoptotic cell membrane receptor. Antimicrob Agents Chemother. 2016;60:4206–4216. doi:10.1128/AAC.03130-15
  • Wang B, Timilsena YP, Blanch E, Adhikari B. Lactoferrin: structure, function, denaturation and digestion. Crit Rev Food Sci Nutr. 2019;59:580–596. doi:10.1080/10408398.2017.1381583
  • Nairz M, Schroll A, Sonnweber T, Weiss G. The struggle for iron – a metal at the host-pathogen interface. Cell Microbiol. 2010;12:1691–1702. doi:10.1111/j.1462-5822.2010.01529.x
  • Eric Stenfors L, Marie Bye H, Vorland LH, Nord H. Remarkable attachment of lactoferrin to Streptococcus pyogenes during acute pharyngotonsillitis. Acta Otolaryngol. 2001;121(5):637–642. doi:10.1080/00016480117451
  • Velusamy SK, Fine H, Velliyagounder K. Prophylactic effect of human lactoferrin against Streptococcus mutans bacteremia in lactoferrin knockout mice. Microbes Infect. 2014;16(9):762–767. doi:10.1016/j.micinf.2014.07.009
  • Kushwaha N, Kamat M, Banjade B, et al. Prevalence of group-a streptococcal infection among school children of urban community. IJIMS. 2014;1(5):249–256l.
  • Abd Al-Kareem F, Abbas A, Hussein M. Comparative study of the Antibody Responses to Streptococcus pyogenes between school children carriers and patients with Tonsillitis. Iraqi J Sci. 2014;55(2A):403–410.
  • Kumar A, Kumari N. Evaluate the effectiveness of tonsillectomy and long-acting penicillin on the levels of the antistreptolysin O titer in children with recurrent tonsillitis. Int J Res Med Sci. 2019;7(5):1692–1695. doi:10.18203/2320-6012.ijrms20191660
  • Benson KF, Carter SG, Patterson KM, Patel D, Jensen GS. A novel extract from bovine colostrum whey supports anti-bacterial and anti-viral innate immune functions in vitro and in vivo. Prev Med. 2012;54:116–123. doi:10.1016/j.ypmed.2011.12.023
  • Yoshioka Y, Kudo S, Nishimura H, et al. Oral administration of bovine colostrum stimulates intestinal intraepithelial lymphocytes to polarize Th1-type in mice. Int Immunopharmacol. 2005;5:581–590. doi:10.1016/j.intimp.2004.11.005
  • Drago ME. Lactoferrina: producción industrial y aplicaciones. Rev Mex Ciencias Farmacéuticas. 2007;38:30–38.
  • Goldman IL, Deikin AV, Sadchikova ER. Human lactoferrin can be alternative to antibiotics. In: Proceedings of the World Medical Conference. 2010:27–38.
  • Leon N, Reyes M, Ordaz C, de la Garza M. Microbicidal action of lactoferrin and lactoferricin and their synergistic effect with metronidazole in Entamoeba histolytica. Biochem Cell Biol. 2006;84:327–336. doi:10.1139/o06-060